Loading…
Researchers at the Icahn School of Medicine at Mount Sinai determined the full cryo-EM structure of AASS, the enzyme that starts the lysine breakdown pathway. The study, published in Science Advances on November 13, identified a hinge-like regulatory region that controls the enzyme's activity.
The structure gives drug developers a first detailed target for glutaric aciduria type 1, a disorder that can cause brain damage in infants.
This is a human medical research result with no direct effect on feed grain, oilseed or protein supply, demand or prices.
tmlnews.techAnika WellsNov 14, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
